Dana Yaacov-Garbeli is CFO at Entera Bio Ltd. (ENTX). They have made 1 open-market trade across 1 company since 2022, most recently 2026-05-07.
CIK 0001909822
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $30K since 2022, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ENTX | 171,441 | $460K |
Shares reported on the most recent Form 4, priced at the 2026-05-08 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ENTX | BUY | 2022-11-11 | 2022-11-15 | $0.53 | $30K | +8.7% | +0.2% | +43.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.